Works matching IS 27245985 AND DT 2022 AND VI 68 AND IP 4


Results: 28
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Effects of Robuvit on the progression of non-alcoholic fatty liver disease.

    Published in:
    Minerva Gastroenterology, 2022, v. 68, n. 4, p. 434, doi. 10.23736/S2724-5985.22.03201-6
    By:
    • BELCARO, Gianni;
    • COX, David M.;
    • CESARONE, M. Rosaria;
    • GIZZI, Giuseppe;
    • PELLEGRINI, Luciano;
    • SCIPIONE, Claudia;
    • SCIPIONE, Valeria;
    • DUGALL, Mark;
    • Shu HU;
    • CORSI, Marcello;
    • FERAGALLI, Beatrice;
    • COTELLESE, Roberto
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27

    Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma.

    Published in:
    Minerva Gastroenterology, 2022, v. 68, n. 4, p. 378, doi. 10.23736/S2724-5985.21.03006-0
    By:
    • NICOLOSI, Aurora;
    • GAIA, Silvia;
    • RISSO, Alessandra;
    • ROSSO, Chiara;
    • ROLLE, Emanuela;
    • ABATE, Maria L.;
    • OLIVERO, Antonella;
    • ARMANDI, Angelo;
    • RIBALDONE, Davide G.;
    • CARUCCI, Patrizia;
    • FAGOONEE, Sharmila;
    • PELLICANO, Rinaldo;
    • SARACCO, Giorgio M.;
    • BUGIANESI, Elisabetta;
    • CAVIGLIA, Gian P.
    Publication type:
    Article
    28